Published in Eur Heart J on January 22, 2007
Predictors and outcomes of early coronary angiography in patients with prior coronary artery bypass surgery presenting with non-ST elevation myocardial infarction. Open Heart (2014) 0.78
Clinical indicators for recurrent cardiovascular events in acute coronary syndrome patients treated with statins under routine practice in Thailand: an observational study. BMC Cardiovasc Disord (2015) 0.75
Management and Prevention of Saphenous Vein Graft Failure: A Review. Cardiol Ther (2017) 0.75
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J (2009) 2.68
The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart (2010) 2.24
Guidewire withdrawal in ascending aorta increases cerebral microembolism during coronary angiography: a randomized comparison of two guidewire techniques. J Invasive Cardiol (2014) 1.96
Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation (2011) 1.85
Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J (2006) 1.70
Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis (2006) 1.66
Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol (2007) 1.66
Cerebral microembolism during coronary angiography: a randomized comparison between femoral and radial arterial access. Stroke (2011) 1.58
Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Arch Intern Med (2010) 1.57
Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction. Circ Res (2012) 1.55
Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost (2005) 1.51
Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue. Thromb Haemost (2012) 1.47
Cardiac fatigue in long-distance runners is associated with ventricular repolarization abnormalities. Heart Rhythm (2008) 1.45
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). J Am Coll Cardiol (2010) 1.44
Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney Int (2011) 1.43
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J (2003) 1.41
Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med (2009) 1.41
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion. Thromb Res (2011) 1.40
The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination. JACC Cardiovasc Interv (2011) 1.38
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci U S A (2007) 1.37
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis (2005) 1.26
Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem (2004) 1.25
Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry. Circ Cardiovasc Interv (2009) 1.25
Gender differences in management and outcome in non-ST-elevation acute coronary syndrome. Heart (2006) 1.22
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Am J Cardiol (2010) 1.20
Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol (2010) 1.10
A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutr Metab Cardiovasc Dis (2006) 1.10
Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson (2010) 1.07
Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart (2010) 1.04
Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol (2004) 1.00
Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction. Heart (2010) 1.00
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). J Am Coll Cardiol (2009) 0.96
How to set up an effective national primary angioplasty network: lessons learned from five European countries. EuroIntervention (2009) 0.96
Daylight saving time shifts and incidence of acute myocardial infarction--Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Sleep Med (2012) 0.94
Marked differences in CRP genotype frequencies between the Fulani and sympatric ethnic groups in Africa. Malar J (2009) 0.94
Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome. Cardiovasc Revasc Med (2012) 0.93
Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial. Am Heart J (2004) 0.91
Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J (2005) 0.90
Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis (2006) 0.90
Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. J Interferon Cytokine Res (2010) 0.87
Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria. J Am Coll Cardiol (2009) 0.86
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. Eur Heart J (2009) 0.86
Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis (2004) 0.85
The effect of early mobilisation for patient undergoing coronary angiography; a pilot study with focus on vascular complications and back pain. Eur J Cardiovasc Nurs (2010) 0.85
Endothelial activation with prothrombotic response in irradiated microvascular recipient veins. J Plast Reconstr Aesthet Surg (2010) 0.83
Technical skills assessment in a coronary angiography simulator for construct validation. Simul Healthc (2013) 0.83
Systemic inflammation activates the nuclear factor-kappaB regulatory pathway in adipose tissue. Am J Physiol Endocrinol Metab (2010) 0.82
Hormonal regulation of circulating C-reactive protein in men. Clin Chem (2005) 0.82
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden. Clin Ther (2005) 0.82
Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol (2010) 0.81
The inflammatory response to femoral arterial closure devices: a randomized comparison among FemoStop, AngioSeal, and Perclose. Cardiovasc Intervent Radiol (2008) 0.81
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost (2004) 0.81
Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controls. Atherosclerosis (2006) 0.80
Increased long-term expression of pentraxin 3 in irradiated human arteries and veins compared to internal controls from free tissue transfers. J Transl Med (2013) 0.80
Large differences between patients with acute myocardial infarction included in two Swedish health registers. Scand J Public Health (2013) 0.80
Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Thromb Haemost (2007) 0.80
Cytokine gene haplotypes with a potential effect on susceptibility to malaria in sympatric ethnic groups in Mali. Infect Genet Evol (2011) 0.80
Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome. EuroIntervention (2011) 0.79
Association of a single nucleotide polymorphism in the C-reactive protein gene (-286) with susceptibility to Plasmodium falciparum malaria. Mol Med (2009) 0.79
Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention (2016) 0.79
Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction? Thromb Haemost (2005) 0.78
No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction. Blood Coagul Fibrinolysis (2003) 0.78
Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years. Atherosclerosis (2012) 0.78
Although women are less likely to be admitted to coronary care units, they are treated equally to men and have better outcome. A prospective cohort study in patients with non ST-elevation acute coronary syndromes. Acute Card Care (2009) 0.78
Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. BMC Cardiovasc Disord (2013) 0.78
Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem (2005) 0.77
The use of fluoroscopy to construct learning curves for coronary angiography. Catheter Cardiovasc Interv (2011) 0.77
Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels. Am J Cardiol (2006) 0.77
Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J (2007) 0.77
The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin. Int J Cardiol (2012) 0.77
Early treatment with abciximab in patients with ST elevation myocardial infarction results in a high rate of normal or near normal blood flow in the infarct related artery. Acute Card Care (2010) 0.77
Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion. Int J Cardiol (2013) 0.76
Coagulation factor VII and inflammatory markers in patients with coronary heart disease. Blood Coagul Fibrinolysis (2007) 0.76
Coronary angiography of patients with a previous coronary artery by-pass operation is associated with a three times increased risk for neurological complications. A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Scand Cardiovasc J (2009) 0.75
Authors’ reply. J Invasive Cardiol (2014) 0.75
Acute triglyceridemia and endothelial function. Am J Cardiol (2002) 0.75
Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA. Heart (2010) 0.75
The role of a simulator-based course in coronary angiography on performance in real life cath lab. BMC Med Educ (2014) 0.75
[International and national consensus on the best post-resuscitation care after cardiac arrest]. Lakartidningen (2010) 0.75
Platelet function and myocardial injury during percutaneous coronary intervention. J Thromb Thrombolysis (2002) 0.75
Point-of-care testing of clopidogrel-mediated platelet inhibition and risk for cardiovascular events after coronary angiography with or without percutaneous coronary intervention. Blood Coagul Fibrinolysis (2014) 0.75
Climbing the cardiology career ladder: Sweden. Interview by Barry Shurlock. Circulation (2007) 0.75
Limited prognostic value of noninvasive assessment of reperfusion by continuous vectorcardiography in an unselected cohort of patients with acute ST-elevation myocardial infarction treated with thrombolysis. J Electrocardiol (2007) 0.75
Virtual reality training in coronary angiography and its transfer effect to real-life catheterisation lab. EuroIntervention (2016) 0.75
[Coronary computer tomography--time for reflection. A survey of the current knowledge]. Lakartidningen (2009) 0.75
[Myocardial infarction with normal coronary arteries in women. MINCA--a specific type of myocardial infarction]. Lakartidningen (2007) 0.75
[The cholesterol hypothesis holds. Cholesterol is a risk factor for atherosclerosis according to current status report]. Lakartidningen (2010) 0.75
Relevance of genetic polymorphisms in inflammatory response to percutaneous coronary intervention. Scand J Clin Lab Invest (2009) 0.75
[Coronary disease is investigated and treated with advantage via catheter]. Lakartidningen (2011) 0.75
[Takotsubo syndrome possible also in obstructive coronary vessel disease. The conditions do not exclude each other according to two case reports]. Lakartidningen (2011) 0.75
Deadly myocardial fibrosis of unknown etiology in adolescence. Cardiology (2006) 0.75
Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI. J Electrocardiol (2005) 0.75